Meribank Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	97.44	165.09	399.46	85.16	192.15
Short-Term Investments	131.9	-	-	122.7	94.1
Cash & Short-Term Investments	229.34	165.09	399.46	207.86	286.25
Cash Growth	38.92%	-58.67%	92.18%	-27.39%	194.21%
Accounts Receivable	187.12	158.22	128.63	146.97	147.53
Other Receivables	6.08	8.82	6.5	5.47	1.63
Receivables	193.21	167.04	135.13	152.44	149.17
Inventory	6.42	11.24	6.91	8.45	3.6
Prepaid Expenses	40.27	49.6	28.61	24.13	19.87
Other Current Assets	1.39	0.34	0.09	0.02	0.11
Total Current Assets	470.63	393.31	570.19	392.9	458.99
Property, Plant & Equipment	473.71	479.46	162.06	178.19	190.76
Long-Term Investments	39.13	59.57	59.56	25.22	44.45
Goodwill	280.08	282.18	2.87	-	-
Other Intangible Assets	548.24	584.09	31.69	10.22	1.09
Long-Term Deferred Tax Assets	4.26	3.8	2.48	-	-
Other Long-Term Assets	1,060	879.54	233.17	239.8	252.03
Total Assets	2,876	2,682	1,062	846.33	947.32
Accounts Payable	6.92	13.08	12.32	7.6	4.75
Accrued Expenses	60.17	63.31	50.63	45.84	44.57
Current Portion of Long-Term Debt	7.46	7.32	-	-	-
Current Portion of Leases	126.83	70.85	19.23	21.58	18.25
Current Unearned Revenue	22.47	27.33	17.56	14.76	12.97
Other Current Liabilities	23.71	50.35	27.17	19.28	15.34
Total Current Liabilities	247.55	232.23	126.91	109.07	95.87
Long-Term Debt	155.41	162.88	-	-	-
Long-Term Leases	837.96	701.79	14.81	24.25	34.73
Long-Term Unearned Revenue	272.52	258.41	245.7	236.52	228.14
Long-Term Deferred Tax Liabilities	93.51	99.83	1.38	0.65	-
Other Long-Term Liabilities	9.35	9.42	2.02	2.05	2.53
Total Liabilities	1,616	1,465	390.81	372.53	361.27
Common Stock	959.76	879.76	709.76	627.76	627.76
Additional Paid-In Capital	748.27	708.27	233.2	203.24	203.74
Retained Earnings	-454.7	-373.23	-272.2	-350.09	-247.58
Comprehensive Income & Other	-4.19	-9.07	-9.04	-9.71	2.12
Total Common Equity	1,249	1,206	661.73	471.2	586.05
Minority Interest	10.96	11.65	9.46	2.59	-
Shareholders' Equity	1,260	1,217	671.2	473.79	586.05
Total Liabilities & Equity	2,876	2,682	1,062	846.33	947.32
Total Debt	1,128	942.84	34.04	45.83	52.97
Net Cash (Debt)	-898.33	-777.75	365.42	162.03	233.28
Net Cash Growth	-	-	125.53%	-30.54%	752.06%
Net Cash Per Share	-9.84	-9.78	5.81	2.58	3.87
Filing Date Shares Outstanding	95.98	87.98	70.98	62.78	62.78
Total Common Shares Outstanding	95.98	87.98	70.98	62.78	62.78
Working Capital	223.08	161.08	443.27	283.83	363.12
Book Value Per Share	13.02	13.71	9.32	7.51	9.34
Tangible Book Value	420.83	339.46	627.17	460.98	584.96
Tangible Book Value Per Share	4.38	3.86	8.84	7.34	9.32
Land	214.7	214.7	41.08	41.08	41.08
Buildings	107.62	107.62	53.84	53.23	52.95
Machinery	103.23	96.57	76.56	61.45	62.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.